Literature DB >> 15797187

Fatal neurologic involvement in pediatric Wegener's granulomatosis.

Tim Ulinski1, Helene Martin, Brigitte Mac Gregor, Roger Dardelin, Pierre Cochat.   

Abstract

Wegener's granulomatosis is a potentially life-threatening vasculitis with widely variable presentation. Only three pediatric cases with severe central nervous system involvement are reported in the literature. Early fatal outcome as described here is exceptional. This report describes a 13-year-old female with typical skin lesions, proteinuria, and renal failure initially misdiagnosed as a Schoenlein-Henoch purpura. A kidney biopsy revealed severe extracapillary proliferation in 70% of the analyzed glomeruli but no granuloma. In spite of methylprednisolone pulse therapy and oral high-dose prednisone, end-stage renal failure was reached 4 months later, necessitating peritoneal dialysis. Three months later she presented with pulmonary hemorrhage and positive antineutrophil cytoplasmic antibodies suggesting Wegener's granulomatosis. This episode was controlled by methylprednisolone pulses. Seven months later she presented generalized seizures and coma, suggesting central nervous system involvement confirmed by magnetic resonance imaging. Methylprednisolone pulses and intravenous immunoglobulins led to neurologic improvement. Oral methotrexate was then introduced for long-term disease control. Another severe relapse of central nervous system vasculitis did not respond to any applied therapies and led to death 16 months after initial symptoms. This case emphasizes the need for activity scores to identify patients at risk for progressive systemic vasculitis requiring early and long-term aggressive immunosuppressive therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15797187     DOI: 10.1016/j.pediatrneurol.2004.10.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Granulomatosis with polyangiitis (Wegener's granulomatosis): a rare variant of sudden natural death.

Authors:  Birthe Heitkötter; Cornelius Kuhnen; Sven Schmidt; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2017-10-31       Impact factor: 2.686

Review 2.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Pediatric granulomatosis with polyangiitis exhibiting prominent central nervous system symptoms.

Authors:  Tingting Lu; Jian Bao; Dongfang Lin; Hongbing Chen; Wei Qiu; Zhengqi Lu
Journal:  Childs Nerv Syst       Date:  2016-04-11       Impact factor: 1.475

4.  Positivity to p-ANCA in patients with status epilepticus.

Authors:  Edoardo Ferlazzo; Antonio Gambardella; Marina Bellavia; Sara Gasparini; Laura Mumoli; Angelo Labate; Vittoria Cianci; Concetta Russo; Umberto Aguglia
Journal:  BMC Neurol       Date:  2014-07-17       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.